According to Sutro Biopharma's latest financial reports the company's total liabilities are $0.32 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.18 B | 113.74% |
2021-12-31 | $88.84 M | 43.15% |
2020-12-31 | $62.06 M | 5.94% |
2019-12-31 | $58.58 M | -36.05% |
2018-12-31 | $91.6 M | -38.84% |
2017-12-31 | $0.14 B | -6.5% |
2016-12-31 | $0.16 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 93.87% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -96.26% | ๐บ๐ธ USA |